a5IA from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
a5IA

Get Pricing

Description

a5IA is a nootropic drug invented in 2004 by a team working for Merck, Sharp and Dohme, which acts as a subtype-selective inverse agonist at the benzodiazepine binding site on the GABAA receptor